Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2411

1.

In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT2C Receptor Interaction With Phosphatase and Tensin Homolog.

Soto CA, Du HC, Fox RG, Yang T, Hooson J, Anastasio NC, Gilbertson SR, Cunningham KA.

Front Pharmacol. 2019 Aug 23;10:907. doi: 10.3389/fphar.2019.00907. eCollection 2019.

2.

Nanofibrillar Ionic Polymer Composites Enable High Modulus Ion-Conducting Membranes.

Fox RJ, Yu D, Hegde M, Kumbhar AS, Madsen LA, Dingemans TJ.

ACS Appl Mater Interfaces. 2019 Sep 11. doi: 10.1021/acsami.9b10921. [Epub ahead of print]

PMID:
31507155
3.

Ramsey-Bordé Matter-Wave Interferometry for Laser Frequency Stabilization at 10^{-16} Frequency Instability and Below.

Olson J, Fox RW, Fortier TM, Sheerin TF, Brown RC, Leopardi H, Stoner RE, Oates CW, Ludlow AD.

Phys Rev Lett. 2019 Aug 16;123(7):073202. doi: 10.1103/PhysRevLett.123.073202.

PMID:
31491125
4.

Chronic poly-drug administration damages adult mouse brain neural stem cells.

McGrath EL, Schlagal CR, Cortez I, Dunn TJ, Gao J, Fox RG, Stutz SJ, Kuo YF, Hommel JD, Dineley KT, Cunningham KA, Kaphalia BS, Wu P.

Brain Res. 2019 Aug 29;1723:146425. doi: 10.1016/j.brainres.2019.146425. [Epub ahead of print]

PMID:
31473223
5.

Vitamin D and MRI measures in progressive multiple sclerosis.

Abbatemarco JR, Fox RJ, Li H, Ontaneda D.

Mult Scler Relat Disord. 2019 Aug 13;35:276-282. doi: 10.1016/j.msard.2019.08.014. [Epub ahead of print]

PMID:
31445221
6.

An experimental test for body size-dependent effects of male harassment and an elevated copulation rate on female fecundity and offspring performance.

Iglesias-Carrasco M, Fox RJ, Vega-Trejo R, Jennions MD, Head ML.

J Evol Biol. 2019 Aug 23. doi: 10.1111/jeb.13526. [Epub ahead of print]

PMID:
31444811
7.

Understanding the Efficiency of Splenic Hemangiosarcoma Diagnosis Using Monte Carlo Simulations.

Herman EJ, Stern AW, Fox RJ, Dark MJ.

Vet Pathol. 2019 Aug 18:300985819868732. doi: 10.1177/0300985819868732. [Epub ahead of print]

PMID:
31422751
8.

Understanding outcome metrics of the revised NIOSH lifting equation.

Fox RR, Lu ML, Occhipinti E, Jaeger M.

Appl Ergon. 2019 Nov;81:102897. doi: 10.1016/j.apergo.2019.102897. Epub 2019 Jul 23.

PMID:
31422239
9.

Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4).

Brooks CA, Barton LS, Behm DJ, Eidam HS, Fox RM, Hammond M, Hoang TH, Holt DA, Hilfiker MA, Lawhorn BG, Patterson JR, Stoy P, Roethke TJ, Ye G, Zhao S, Thorneloe KS, Goodman KB, Cheung M.

ACS Med Chem Lett. 2019 Jul 15;10(8):1228-1233. doi: 10.1021/acsmedchemlett.9b00274. eCollection 2019 Aug 8.

PMID:
31413810
10.

How have advances in CT dosimetry software impacted estimates of CT radiation dose and cancer incidence? A comparison of CT dosimetry software: Implications for past and future research.

Maxwell S, Fox R, McRobbie D, Bulsara M, Doust J, O'Leary P, Slavotinek J, Stubbs J, Moorin R.

PLoS One. 2019 Aug 14;14(8):e0217816. doi: 10.1371/journal.pone.0217816. eCollection 2019.

11.

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis.

Dutta R, Mahajan KR, Nakamura K, Ontaneda D, Chen J, Volsko C, Dudman J, Christie E, Dunham J, Fox RJ, Trapp BD.

J Vis Exp. 2019 Jul 19;(149). doi: 10.3791/59511.

PMID:
31380830
12.

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.

McGinley MP, Cola PA, Fox RJ, Cohen JA, Corboy JJ, Miller D.

Mult Scler. 2019 Aug 1:1352458519867314. doi: 10.1177/1352458519867314. [Epub ahead of print]

PMID:
31368401
13.

Women's views on screening for Type 2 diabetes after gestational diabetes: a systematic review, qualitative synthesis and recommendations for increasing uptake.

Dennison RA, Fox RA, Ward RJ, Griffin SJ, Usher-Smith JA.

Diabet Med. 2019 Jul 18. doi: 10.1111/dme.14081. [Epub ahead of print] Review.

PMID:
31317569
14.

Demyelinating lesions and progressive MS: Location, location, location.

Yeh EA, Fox RJ.

Neurology. 2019 Aug 13;93(7):283-284. doi: 10.1212/WNL.0000000000007933. Epub 2019 Jul 9. No abstract available.

PMID:
31289147
15.

Perceived Discrimination and Cardiometabolic Risk Among US Hispanics/Latinos in the HCHS/SOL Sociocultural Ancillary Study.

Fox RS, Carnethon MR, Gallo LC, Wiley JF, Isasi CR, Daviglus ML, Cai J, Davis SM, Giachello AL, Gonzalez P, McCurley JL, Schneiderman N, Penedo FJ.

Int J Behav Med. 2019 Aug;26(4):331-342. doi: 10.1007/s12529-019-09782-7.

PMID:
31236872
16.

Too Much Compromise in Today's CRISPR Pipelines.

Fox R.

CRISPR J. 2019 Jun;2:143-145. doi: 10.1089/crispr.2019.0015.

17.

The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials.

Chataway J, Weir CJ, Fox RJ.

Mult Scler. 2019 Jun 20:1352458519856985. doi: 10.1177/1352458519856985. [Epub ahead of print] No abstract available.

PMID:
31218918
18.

Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.

Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, Cramp ME, Cooper C, Foxton M, Rodriguez CF, Esteban R, Hyland R, Lu S, Kirby BJ, Meng A, Markova S, Dvory-Sobol H, Osinusi AO, Bruck R, Ampuero J, Ryder SD, Agarwal K, Fox R, Shaw D, Haider S, Willems B, Lurie Y, Calleja JL, Gane EJ.

J Hepatol. 2019 Jun 11. pii: S0168-8278(19)30343-5. doi: 10.1016/j.jhep.2019.05.028. [Epub ahead of print]

19.

Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment.

Berhane S, Fox R, García-Fiñana M, Cucchetti A, Johnson P.

Br J Cancer. 2019 Jul;121(2):117-124. doi: 10.1038/s41416-019-0488-4. Epub 2019 Jun 11.

PMID:
31182766
20.

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.

Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.

BMC Neurol. 2019 Jun 8;19(1):116. doi: 10.1186/s12883-019-1337-z.

21.

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.

Marrie RA, Dufault B, Tyry T, Cutter GR, Fox RJ, Salter A.

Mult Scler. 2019 Jun 4:1352458519852722. doi: 10.1177/1352458519852722. [Epub ahead of print]

PMID:
31161917
22.

Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy.

Fox RS, Ancoli-Israel S, Roesch SC, Merz EL, Mills SD, Wells KJ, Sadler GR, Malcarne VL.

Support Care Cancer. 2019 Jun 3. doi: 10.1007/s00520-019-04834-w. [Epub ahead of print]

PMID:
31161437
23.

A critical analysis of Powell's results on the interdivision time distribution.

Quedeville V, Morchain J, Villedieu P, Fox RO.

Sci Rep. 2019 Jun 3;9(1):8165. doi: 10.1038/s41598-019-44606-4.

24.

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.

Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K.

PLoS One. 2019 Jun 3;14(6):e0217471. doi: 10.1371/journal.pone.0217471. eCollection 2019.

25.

Feature article: Discovery of vascular Rho kinase (ROCK) inhibitory peptides.

Abbasgholizadeh R, Zhang H, Craft JW Jr, Bryan RM Jr, Bark SJ, Briggs JM, Fox RO, Agarkov A, Zimmer WE, Gilbertson SR, Schwartz RJ.

Exp Biol Med (Maywood). 2019 Aug;244(11):940-951. doi: 10.1177/1535370219849581. Epub 2019 May 27. No abstract available.

PMID:
31132884
26.

Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).

Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ.

Mol Genet Genomic Med. 2019 Jul;7(7):e00736. doi: 10.1002/mgg3.736. Epub 2019 May 13.

27.

Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Mult Scler. 2019 May 13:1352458519845836. doi: 10.1177/1352458519845836. [Epub ahead of print]

PMID:
31079537
28.

The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments.

Salter A, Fox RJ, Tyry T, Cutter G, Marrie RA.

Mult Scler Relat Disord. 2019 Jun;31:165-172. doi: 10.1016/j.msard.2019.04.014. Epub 2019 Apr 13.

PMID:
31063935
29.

Integrating PROMIS® computerized adaptive tests into a web-based intervention for prostate cancer.

Fox RS, Moreno PI, Yanez B, Estabrook R, Thomas J, Bouchard LC, McGinty HL, Mohr DC, Begale MJ, Flury SC, Perry KT, Kundu SD, Penedo FJ.

Health Psychol. 2019 May;38(5):403-409. doi: 10.1037/hea0000672.

PMID:
31045423
30.

Treatment of Sjögren's syndrome: current therapy and future directions.

Fox RI, Fox CM, Gottenberg JE, Dörner T.

Rheumatology (Oxford). 2019 Apr 26. pii: kez142. doi: 10.1093/rheumatology/kez142. [Epub ahead of print]

PMID:
31034046
31.

New Approaches in Hypertension Management: a Review of Current and Developing Technologies and Their Potential Impact on Hypertension Care.

Kitt J, Fox R, Tucker KL, McManus RJ.

Curr Hypertens Rep. 2019 Apr 25;21(6):44. doi: 10.1007/s11906-019-0949-4. Review.

32.

Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression.

Bowlt Blacklock KL, Birand Z, Selmic LE, Nelissen P, Murphy S, Blackwood L, Bass J, McKay J, Fox R, Beaver S, Starkey M.

Sci Rep. 2019 Apr 24;9(1):6511. doi: 10.1038/s41598-019-42839-x.

33.

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer.

Evans DG, Thomas S, Caunt J, Burch A, Brentnall AR, Roberts L, Howell A, Wilson M, Fox R, Hillier S, Sibbering DM, Moss S, Wallis MG, Eccles DM; FH02 study group, Duffy S.

EClinicalMedicine. 2019 Jan;7:39-46. doi: 10.1016/j.eclinm.2019.01.005.

34.

Sexual selection, phenotypic plasticity and female reproductive output.

Fox RJ, Fromhage L, Jennions MD.

Philos Trans R Soc Lond B Biol Sci. 2019 Mar 18;374(1768):20180184. doi: 10.1098/rstb.2018.0184.

PMID:
30966965
35.

Beyond buying time: the role of plasticity in phenotypic adaptation to rapid environmental change.

Fox RJ, Donelson JM, Schunter C, Ravasi T, Gaitán-Espitia JD.

Philos Trans R Soc Lond B Biol Sci. 2019 Mar 18;374(1768):20180174. doi: 10.1098/rstb.2018.0174.

36.

A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma.

Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T.

Cell. 2019 Apr 18;177(3):572-586.e22. doi: 10.1016/j.cell.2019.03.010. Epub 2019 Apr 4.

PMID:
30955884
37.

Psychosocial and neighborhood correlates of health-related quality of life: A multi-level study among Hispanic adults.

Mills SD, Fox RS, Bohan S, Roesch SC, Sadler GR, Malcarne VL.

Cultur Divers Ethnic Minor Psychol. 2019 Apr 1. doi: 10.1037/cdp0000274. [Epub ahead of print]

PMID:
30932506
38.

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group.

Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Erratum in: Lancet Oncol. 2019 Apr 2;:.

PMID:
30922733
39.

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.

Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ.

Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27.

40.

Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.

Gulliford MC, Juszczyk D, Prevost AT, Soames J, McDermott L, Sultana K, Wright M, Fox R, Hay AD, Little P, Moore M, Yardley L, Ashworth M, Charlton J.

Health Technol Assess. 2019 Mar;23(11):1-70. doi: 10.3310/hta23110.

41.

Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance.

Muraro PA, Scolding NJ, Fox RJ.

Neurology. 2019 Mar 19;92(12):586. doi: 10.1212/WNL.0000000000007128. No abstract available.

PMID:
30886076
42.

Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B.

Fox RK, Taddei TH, Kaplan DE.

JAMA Intern Med. 2019 May 1;179(5):640-641. doi: 10.1001/jamainternmed.2018.8314. No abstract available.

PMID:
30882884
43.

A survey of risk tolerance to multiple sclerosis therapies.

Fox RJ, Cosenza C, Cripps L, Ford P, Mercer M, Natarajan S, Salter A, Tyry T, Cofield SS.

Neurology. 2019 Apr 2;92(14):e1634-e1642. doi: 10.1212/WNL.0000000000007245. Epub 2019 Mar 13.

44.

Impact of lenalidomide on collected hematopoietic myeloid and erythroid progenitors: peripheral stem cell collection may not be affected.

Dosani T, Covut F, Pinto R, Kim BG, Ali N, Beck R, Maitta R, Downes K, Fox R, Reese J, de Lima M, Malek E.

Leuk Lymphoma. 2019 Mar 7:1-8. doi: 10.1080/10428194.2019.1573367. [Epub ahead of print]

PMID:
30845862
45.

Assessment of Trauma Symptoms in Toddlers and Preschoolers Living in Poverty.

Bollens SH, Fox RA.

Child Maltreat. 2019 Aug;24(3):275-285. doi: 10.1177/1077559519830790. Epub 2019 Mar 6.

PMID:
30841724
46.

Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.

Gulliford MC, Prevost AT, Charlton J, Juszczyk D, Soames J, McDermott L, Sultana K, Wright M, Fox R, Hay AD, Little P, Moore MV, Yardley L, Ashworth M.

BMJ. 2019 Feb 12;364:l236. doi: 10.1136/bmj.l236.

47.

Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA.

Mult Scler Relat Disord. 2019 Apr;29:86-93. doi: 10.1016/j.msard.2019.01.031. Epub 2019 Jan 24.

PMID:
30690340
48.

Making Space for Community Critical Methodology: Stories from the Australian Context.

Fox R, Nic Giolla Easpaig B, Watson L.

Am J Community Psychol. 2019 Mar;63(1-2):227-238. doi: 10.1002/ajcp.12302. Epub 2019 Jan 25.

PMID:
30681734
49.

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

Kaplan DE, Serper MA, Mehta R, Fox R, John B, Aytaman A, Baytarian M, Hunt K, Albrecht J, Njei B, Taddei TH; VOCAL Study Group.

Gastroenterology. 2019 May;156(6):1693-1706.e12. doi: 10.1053/j.gastro.2019.01.026. Epub 2019 Jan 18.

50.

Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND): protocol for a randomised feasibility trial.

Morris E, Aveyard P, Dyson P, Noreik M, Bailey C, Fox R, Hoffman K, Tan GD, Jebb SA.

BMJ Open. 2019 Jan 17;9(1):e026460. doi: 10.1136/bmjopen-2018-026460.

Supplemental Content

Support Center